Responsible for executing US Adverse Event and Pharmacovigilance activities as required by FDA Regulations. Provide support and oversight in drug safety related activities including Product Quality Complaints and Medical Information activities. Zydus Pharmaceuticals (USA) Inc. is a globally integrated generic pharmaceutical company with a focus on providing high service, quality, and affordable products. Our US leadership, which has over 60 years of US generic market experience, understands the customer’s business which allows Zydus the ability to provide unique models to help drive their customer’s success. Our parent company, Zydus Cadila, has a large presence in global markets, including relationships with many top tier international pharmaceutical companies. Based on a manufacturing and development history that spans over 50 years, it is the 4th largest pharmaceutical company in India.
Zydus Pharmaceuticals (USA) Inc. has been providing quality, affordable generic drugs to the US market for over 15 years. Zydus USA is the US generics division of Zydus Lifesciences Limited and has grown to become one of the top 10 pharmaceutical companies in the US by unbranded dispensed prescriptions. Exceptional service to both customers and patients who rely on our products has been a key driver for the company’s success. With a mission of growth, Zydus USA is focused on expanding its portfolio of complex generics, including modified release oral solids, transdermals, injectables, and oral suspensions. Product-specific questions should be directed to Zydus USA’s Medical Affairs team. To report a product complaint or adverse event related to a Zydus USA product, please contact us at 877-993-8779 Prompt 2 or medicalaffairs@zydususa.com. You are also encouraged to report negative side effects of prescription drugs to the FDA (www.fda.gov/medwatch or call 1-800-FDA-1088).
View company profile →